Protagonist Therapeutics Inc (PTGX)

followers · Follow 1 like

Sector:	HEALTH CARE
Industry:	BIOTECHNOLOGY & LIFE SCIENCES
SIC:	PHARMACEUTICAL PREPARATIONS
CEO:	Dinesh V. Patel
Employees:	120
Web site:	protagonist-inc.com
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160 (510) 474-0170

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Protagonist Therapeutics, Inc. discovers and develops peptide-based therapeutic drugs. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis. PN-943, an oral, alpha-4-beta-7 integrin-specific antagonist peptide, is in clinical trials.

Please log in first to see chart

Protagonist Therapeutics Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available